'Huge Upside Potential' on Firm That Turns Plastic Waste into Synthetic Fuels

Research Report
  ()
The rationale for investing in this company is provided in a Pareto Securities report. read more >

Junior Explorer Moves Forward in 'Prime Gold Real Estate'

Contributed Opinion
  ()
Jay Taylor of J. Taylor's Gold, Energy & Tech Stocks examines the prospects of a company working in the exploration and development of Larder gold deposits along the Cadillac-Larder Lake Fault in Ontario. read more >

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

  ()
Shares of Aurinia Pharmaceuticals traded much higher after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20. read more >
News Update

AR Tech Company Expands Deal with Manufacturer of James Bond PPK

News Update
  ()
The firm will now provide its Web-based three-dimensional, augmented reality service to the client. read more >
News Update

Gold Company's Sale of Colombia Project Closes

News Update
  ()
The company will use the proceeds to explore its Nevada asset. read more >
News Update

AR Tech Firm Reports Record November Revenue, Gross Profit

News Update
  ()
Increased sales spurred the growth during the month. read more >
News Update

Royalty Company Closes Line of Credit Deal with Eric Sprott

News Update
  ()
The $6 million facility is available to the Vancouver-based firm until Nov. 29, 2021. read more >
News Update

Explorer to Sell Interest in Nevada Gold Project

News Update
  ()
In the arrangement, the company will garner a 1% net smelter return royalty. read more >
News Update

Bitumen Resource Estimate Completed for Alberta Asset

News Update
  ()
The report outlines a development plan for the project. read more >

Protagonist Therapeutics Shares Trade Up 70% on Phase 2 Transfusion Trial Results

  ()
Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia. read more >

Expert Investing Ideas

"GBR is a hot stock with a phenomenal gold discovery."

–Gwen Preston, The Maven Letter


"AZZ's UrAsia sale brings cash and an NSR on future production."

–Gerardo del Real, Junior Mining Monthly


"LIO shouldn't lack for news flow in the new year."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"GBR plans to raise CA$14.6M in a flowthrough placement."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"NTAR could well turn out to be a CA$20+ stock."

–Clive Maund, CliveMaund.com


"ELY should still have a very healthy treasury."

–Thibaut Lepouttre, Caesars Report


"We are initiating coverage on VIV."

–David Bautz, Zacks Small-Cap Research


"POE's Indonesia well was finally spudded!"

–Chen Lin, What Is Chen Buying? What Is Chen Selling?


Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

Contributed Opinion
  ()
Daniel Carlson of Tailwinds Research initiates coverage on this clinical-stage biotech whose drug candidate works to strengthen the innate immune system. read more >
News Update

Cannabis Producer Signs Supply Contract with Province of Alberta

News Update
  ()
To start, the company will introduce its premium brand of dried flower there. read more >

Immuno-Oncology Firm Expands Agreement with AbbVie

Research Report
  ()
The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report. read more >
News Update

Company Vies for New Brunswick Cannabis Contract

News Update
  ()
The opportunity is one of the largest in retail cannabis in Canada. read more >